Dexrazoxane Injection, Powder, Lyophilized, For Solution
Product Images NDC 68083-195

6 FDA label images from Gland Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dexrazoxane (NDC 68083-195). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dexrazoxane-spl-structure (Dexrazoxane Spl Structure)

Dexrazoxane-spl-structure (Dexrazoxane Spl Structure)
Chemical structure of Dexrazoxane, illustrating its molecular configuration with two connected cyclic amide groups and methyl substitution, corresponding to the active ingredient Dexrazoxane for Injection.*
FDA Label Image

Dexrazoxane-spl-image1 (Dexrazoxane Spl Image1)

Dexrazoxane-spl-image1 (Dexrazoxane Spl Image1)
A bar chart comparing the number of patients across cumulative doses of Doxorubicin (mg/m²) between two treatment groups: FAC/Dexrazoxane and FAC. The x-axis represents cumulative doses from 350 to 1000+ mg/m², and the y-axis shows the number of patients, ranging from 0 to 120. FAC/Dexrazoxane group bars are white, FAC group bars are black, illustrating patient count distribution by dose.*
FDA Label Image

Dexrazoxane-spl-500mg-label (Dexrazoxane Spl 500mg Label)

Dexrazoxane-spl-500mg-label (Dexrazoxane Spl 500mg Label)
Label for Dexrazoxane for Injection 500 mg per vial, a sterile, pyrogen-free lyophilized powder for intravenous use only. The single-dose vial contains lyophilized powder to be reconstituted prior to administration. Label shows dosage strength, route, handling instructions, manufacturer Gland Pharma Limited, NDC 68083-195-01, and a barcode.*
FDA Label Image

Dexrazoxane-spl-500mg-carton (Dexrazoxane Spl 500mg Carton)

Dexrazoxane-spl-500mg-carton (Dexrazoxane Spl 500mg Carton)
Packaging label for Dexrazoxane for Injection 500 mg per vial, a sterile, pyrogen-free lyophilized powder for intravenous use only. The single-dose vial is manufactured by Gland Pharma Limited, located in Hyderabad, India. The label includes storage instructions, reconstitution details, and a barcode. The NDC is 68083-195-01.*
FDA Label Image

Dexrazoxane-spl-250mg-label (Dexrazoxane Spl 250mg Label)

Dexrazoxane-spl-250mg-label (Dexrazoxane Spl 250mg Label)
Label for Dexrazoxane for Injection 250 mg per vial, a sterile, pyrogen-free lyophilized powder for intravenous use only. It is a single dose vial manufactured by Gland Pharma Limited in Hyderabad, India. The label includes storage instructions, usage directions, barcode, and NDC number 68083-388-01.*
FDA Label Image

Dexrazoxane-spl-250mg-carton (Dexrazoxane Spl 250mg Carton)

Dexrazoxane-spl-250mg-carton (Dexrazoxane Spl 250mg Carton)
Packaging label for Dexrazoxane for Injection 250 mg per vial, a single dose vial of sterile, pyrogen-free lyophilized powder for injection. The label includes storage instructions and dilution directions. Manufactured by Gland Pharma Limited, Hyderabad, India. The NDC is 68083-388-01. The product is for intravenous use only and is Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.